Clinical Trial

An Extension Study of EV-BR1701 Part A1

Name: An Extension Study of EV-BR1701 Part A1 — clinical trial record (NCT07635966)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed

View on ClinicalTrials.gov →

Summary

To determine the long-term immunogenicity more than 5 years after EnVAX-A71 vaccination in the pediatric population aged 2 months to \<6 years when first vaccinated.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-06-03.

Trial Details

NCT Number	NCT07635966
Lead Sponsor	Enimmune Corporation
Conditions	Enterovirus Infections
Enrollment	180 participants
Start Date	2025-09-20
Primary Completion	2025-12-27 (estimated)
Study Completion	2026-04-22 (estimated)
Updated on ClinicalTrials.gov	2026-06-10